about
Accurate and predictive antibody repertoire profiling by molecular amplification fingerprintingInclusion of an RGD Motif Alters Invasin Integrin-Binding Affinity and Specificity.In vivo whole animal fluorescence imaging of a microparticle-based oral vaccine containing (CuInSe(x)S(2-x))/ZnS core/shell quantum dotsApproaches to Mitigate the Unwanted Immunogenicity of Therapeutic Proteins during Drug Development.Advanced Methodologies in High-Throughput Sequencing of Immune Repertoires.Trastuzumab emtansine (T-DM1) renders HER2+ breast cancer highly susceptible to CTLA-4/PD-1 blockade.Advancing Therapeutic Protein Discovery and Development through Comprehensive Computational and Biophysical Characterization
P50
Q28274314-7219587B-F410-4291-BEE6-05687E863CEFQ35970530-8608F433-E2FC-4464-84A3-F6F1A771C27CQ37228729-9CD36105-325D-40A2-BC4F-FF26FBFCD5A8Q39022950-5F00DB49-A16B-4DD8-9C35-11220D286197Q39199530-15B63156-4773-49F3-A6DF-B7070EC49E79Q50908445-1F0052EF-9A22-4926-AEFA-4BEAC754C1B1Q91605793-25A41468-BC44-4906-87C1-A6DF7D2114C1
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Tarik A Khan
@en
Tarik A Khan
@nl
type
label
Tarik A Khan
@en
Tarik A Khan
@nl
prefLabel
Tarik A Khan
@en
Tarik A Khan
@nl
P108
P31
P496
0000-0003-2253-396X